Citrate level in osteoporotic women treated with estrogen and alendronate

被引：0
|
作者：
D'Amelio, P
Beccattini, W
Pescarmona, GP
Isaia, GC
机构：
[1] Univ Turin, Dept Gen Biol & Biochem, I-10124 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
374
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [21] MOLECULAR INVESTIGATIONS OF BONE QUALITY FROM OSTEOPOROTIC WOMEN TREATED WITH ALENDRONATE OR STRONTIUM RANELATE AFTER 12 MONTHS
    Falgayrac, G.
    Cortet, B.
    Olejnik, C.
    Penel, G.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S161 - S161
  • [22] Comparison of bone and total alkaline phosphatase and bone mineral density in postmenopausal osteoporotic women treated with alendronate.
    Watts, NB
    Jenkins, DK
    Geusens, P
    JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 : S551 - S551
  • [23] BONE TISSUE MICROMECHANICAL PROPERTIES ARE ALTERED INDEPENDENTLY OF MINERALIZATION IN OSTEOPOROTIC WOMEN LONG-TERM TREATED ALENDRONATE
    Bala, Yohann
    Depalle, Baptiste
    Douillard, Thierry
    Meille, Sylvain
    Chevalier, Jerome
    Chapurlat, Roland
    Boivin, Georges
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S110 - S111
  • [24] Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women
    Muneaki Ishijima
    Yuko Sakamoto
    Makoto Yamanaka
    Akifumi Tokita
    Keiichiro Kitahara
    Haruka Kaneko
    Hisashi Kurosawa
    Calcified Tissue International, 2009, 85 : 398 - 404
  • [25] Minimum Required Vitamin D Level for Optimal Increase in Bone Mineral Density with Alendronate Treatment in Osteoporotic Women
    Ishijima, Muneaki
    Sakamoto, Yuko
    Yamanaka, Makoto
    Tokita, Akifumi
    Kitahara, Keiichiro
    Kaneko, Haruka
    Kurosawa, Hisashi
    CALCIFIED TISSUE INTERNATIONAL, 2009, 85 (05) : 398 - 404
  • [26] Does Vitamin D Strengthen the Increase in Femoral Neck BMD in Osteoporotic Women Treated with Estrogen?
    M.T. Tuppurainen
    M. Komulainen
    H. Kröger
    R. Honkanen
    J. Jurvelin
    E. Puntila
    A.M. Heikkinen
    E. Alhava
    S. Saarikoski
    Osteoporosis International, 1998, 8 : 32 - 38
  • [27] Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen, MT
    Komulainen, M
    Kroger, H
    Honkanen, R
    Jurvelin, J
    Puntila, E
    Heikkinen, AM
    Alhava, E
    Saarikoski, S
    OSTEOPOROSIS INTERNATIONAL, 1998, 8 (01) : 32 - 38
  • [28] Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate
    Rittmaster, RS
    Bolognese, M
    Ettinger, MP
    Hanley, DA
    Hodsman, AB
    Kendler, DL
    Rosen, CJ
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06): : 2129 - 2134
  • [29] Effect of alendronate treatment for the Chinese postmenopausal women with osteoporotic vertebral fractures
    Or, APC
    Chan, WS
    Lau, EMC
    Leung, PC
    BONE, 2001, 28 (05) : S227 - S227
  • [30] Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women
    Ho, AYY
    Kung, AWC
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1428 - 1433
12345